These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 3925781

  • 1. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R, Carter ND, Jeffery S, Edwards RJ, Watts DC, Watts RL.
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR, Gonzalez CH, Zatz M.
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase III in Duchenne muscular dystrophy.
    Carter ND, Heath R, Jeffery S, Jackson MJ, Newham DJ, Edwards RH.
    Clin Chim Acta; 1983 Sep 30; 133(2):201-8. PubMed ID: 6414742
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
    Zatz M, Karp LE, Rogatko A.
    Am J Med Genet; 1982 Nov 30; 13(3):257-62. PubMed ID: 7180871
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma creatine kinase and myoglobin levels, before and after abortion, in human fetuses at risk for Duchenne muscular dystrophy.
    Edwards RJ, Rodeck CH, Watts DC.
    Am J Med Genet; 1983 Jul 30; 15(3):475-82. PubMed ID: 6881213
    [Abstract] [Full Text] [Related]

  • 16. A nearest neighbour decision rule for EMG detection of carriers of Duchenne muscular dystrophy.
    Hausmanowa-Petrusewicz I, Wierzbicka M, Jozwik A, Szmidt-Salkowska E, Borkowska J.
    Electromyogr Clin Neurophysiol; 1982 Jul 30; 22(6):445-57. PubMed ID: 7140630
    [No Abstract] [Full Text] [Related]

  • 17. Making the most of multiple measurements in estimating carrier probability in Duchenne muscular dystrophy: the Bayesian incorporation of repeated measurements using logistic discrimination.
    Percy ME, Andrews DF, Brasher PM, Rusk AC.
    Am J Med Genet; 1987 Apr 30; 26(4):851-61. PubMed ID: 3591827
    [Abstract] [Full Text] [Related]

  • 18. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
    Zweig MH, Adornato B, Van Steirteghem AC, Engel WK.
    Ann Neurol; 1980 Apr 30; 7(4):324-8. PubMed ID: 7377757
    [Abstract] [Full Text] [Related]

  • 19. Genetic and environmental components of serum creatine kinase (CK) and pyruvate kinase (PK) in normal twins: implication for genetic risks estimates in Duchenne muscular dystrophy carriers.
    Rapaport D, Colletto GM, Zatz M.
    Am J Med Genet; 1988 Oct 30; 31(2):291-8. PubMed ID: 3232697
    [Abstract] [Full Text] [Related]

  • 20. Serum myoglobin in muscular dystrophy.
    Kagen LJ, Moussavi S, Miller SL, Tsairis P.
    Muscle Nerve; 1980 Oct 30; 3(3):221-6. PubMed ID: 7374673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.